Clinical Innovations

Establishing the efficacy and safety of various pharmacological treatments using evidence-based methodologies including meta-analysis and clinical trials.

Using fMRI to understand the development of cognitive, emotional, and motivational brain circuits in adolescents with depression and adolescents with schizophrenia.

Working to understand the brain-based predictors of anxiety and depression in typical youth, clinical populations, and adolescent substance use risk through multimodal imaging and physiological assessment.

The Ibrahim Lab investigates the neural bases of emotion regulation in child mental health. Our research strives to advance understanding of brain systems that play a role in regulating emotions and vulernabilities in these neural networks that can contribute to child mental health.

Studying genetic risk and neurobiological causes and consequences in early onset psychiatric conditions.

Treating and studying neuropsychiatric conditions using novel functional neuroimaging techniques including real-time fMRI neurofeedback and resting state functional connectivity.

Studying underlying neurobiological mechanisms of childhood anxiety disorders, and in developing and testing new therapies based.

Studying behavior and brain systems to better understand the social experiences of people with autism spectrum disorder (ASD) and to improve their quality of life.

Conducting clinical and translational research on neural mechanisms and effectiveness of novel cognitive, behavioral, and neuroscience-based interventions for autism spectrum disorder, pediatric irritability, and Tourette Syndrome.

Providing Pivotal Response Treatment (PRT) to children with ASD and investigating biological markers of treatment response.

Working across countries and disciplines to promote early childhood and youth development research, practice, and policies in the global context.